 | • レポートコード：QAF27561 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアンチエイジング薬市場について種類別（皮膚充填剤、ボツリヌス毒素、その他）、用途別（病院、美容院、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アンチエイジング薬市場の概要 ・世界の主要地域別アンチエイジング薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアンチエイジング薬市場規模2016-2021：種類別（皮膚充填剤、ボツリヌス毒素、その他） ・世界のアンチエイジング薬市場予測2012-2027：種類別（皮膚充填剤、ボツリヌス毒素、その他） ・世界のアンチエイジング薬市場規模2016-2021：用途別（病院、美容院、その他） ・世界のアンチエイジング薬市場予測2012-2027：用途別（病院、美容院、その他） ・アンチエイジング薬のアメリカ市場規模と予測2016-2021 ・アンチエイジング薬のヨーロッパ市場規模と予測2016-2021 ・アンチエイジング薬の中国市場規模と予測2016-2021 ・アンチエイジング薬の日本市場規模と予測2016-2021 ・アンチエイジング薬の東南アジア市場規模と予測2016-2021 ・アンチエイジング薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Allergan、Galderma、LG Life Science、Merz Pharma、Medytox、Hugel、IMEIK、Haohai Bio、Daewoong Pharmaceutical、Bloomage、Suneva Medical、SciVision Biotech） ・アンチエイジング薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アンチエイジング薬の市場動向・機会・課題 ・調査の結論 |
Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The industry’s leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.
Market Analysis and Insights: Global Anti-aging Drugs Market
The global Anti-aging Drugs market was valued at US$ 8823.1 in 2020 and will reach US$ 17320 million by the end of 2027, growing at a CAGR of 11.9% during 2022-2027.
Global Anti-aging Drugs Scope and Market Size
The global Anti-aging Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-aging Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Dermal Fillers
Botulinum Toxin
Others
Segment by Application
Hospital
Beauty Parlor
Others
The Anti-aging Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-aging Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
1 Anti-aging Drugs Market Overview
1.1 Anti-aging Drugs Product Scope
1.2 Anti-aging Drugs Segment by Type
1.2.1 Global Anti-aging Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Anti-aging Drugs Segment by Application
1.3.1 Global Anti-aging Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Beauty Parlor
1.3.4 Others
1.4 Anti-aging Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-aging Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-aging Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-aging Drugs Price Trends (2016-2027)
2 Anti-aging Drugs Estimates and Forecasts by Region
2.1 Global Anti-aging Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-aging Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-aging Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-aging Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Anti-aging Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-aging Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-aging Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-aging Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Anti-aging Drugs Estimates and Projections (2016-2027)
2.4.3 China Anti-aging Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Anti-aging Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-aging Drugs Estimates and Projections (2016-2027)
2.4.6 India Anti-aging Drugs Estimates and Projections (2016-2027)
3 Global Anti-aging Drugs Competition Landscape by Players
3.1 Global Top Anti-aging Drugs Players by Sales (2016-2021)
3.2 Global Top Anti-aging Drugs Players by Revenue (2016-2021)
3.3 Global Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2020)
3.4 Global Anti-aging Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Anti-aging Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-aging Drugs Market Size by Type
4.1 Global Anti-aging Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-aging Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-aging Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-aging Drugs Price by Type (2016-2021)
4.2 Global Anti-aging Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-aging Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-aging Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-aging Drugs Price Forecast by Type (2022-2027)
5 Global Anti-aging Drugs Market Size by Application
5.1 Global Anti-aging Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-aging Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-aging Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-aging Drugs Price by Application (2016-2021)
5.2 Global Anti-aging Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-aging Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-aging Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-aging Drugs Price Forecast by Application (2022-2027)
6 North America Anti-aging Drugs Market Facts & Figures
6.1 North America Anti-aging Drugs Sales by Company
6.1.1 North America Anti-aging Drugs Sales by Company (2016-2021)
6.1.2 North America Anti-aging Drugs Revenue by Company (2016-2021)
6.2 North America Anti-aging Drugs Sales Breakdown by Type
6.2.1 North America Anti-aging Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-aging Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Anti-aging Drugs Sales Breakdown by Application
6.3.1 North America Anti-aging Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-aging Drugs Sales Breakdown by Application (2022-2027)
7 Europe Anti-aging Drugs Market Facts & Figures
7.1 Europe Anti-aging Drugs Sales by Company
7.1.1 Europe Anti-aging Drugs Sales by Company (2016-2021)
7.1.2 Europe Anti-aging Drugs Revenue by Company (2016-2021)
7.2 Europe Anti-aging Drugs Sales Breakdown by Type
7.2.1 Europe Anti-aging Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-aging Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-aging Drugs Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)
8 China Anti-aging Drugs Market Facts & Figures
8.1 China Anti-aging Drugs Sales by Company
8.1.1 China Anti-aging Drugs Sales by Company (2016-2021)
8.1.2 China Anti-aging Drugs Revenue by Company (2016-2021)
8.2 China Anti-aging Drugs Sales Breakdown by Type
8.2.1 China Anti-aging Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-aging Drugs Sales Breakdown by Type (2022-2027)
8.3 China Anti-aging Drugs Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan Anti-aging Drugs Market Facts & Figures
9.1 Japan Anti-aging Drugs Sales by Company
9.1.1 Japan Anti-aging Drugs Sales by Company (2016-2021)
9.1.2 Japan Anti-aging Drugs Revenue by Company (2016-2021)
9.2 Japan Anti-aging Drugs Sales Breakdown by Type
9.2.1 Japan Anti-aging Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-aging Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-aging Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anti-aging Drugs Market Facts & Figures
10.1 Southeast Asia Anti-aging Drugs Sales by Company
10.1.1 Southeast Asia Anti-aging Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-aging Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-aging Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Anti-aging Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-aging Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-aging Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Anti-aging Drugs Market Facts & Figures
11.1 India Anti-aging Drugs Sales by Company
11.1.1 India Anti-aging Drugs Sales by Company (2016-2021)
11.1.2 India Anti-aging Drugs Revenue by Company (2016-2021)
11.2 India Anti-aging Drugs Sales Breakdown by Type
11.2.1 India Anti-aging Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-aging Drugs Sales Breakdown by Type (2022-2027)
11.3 India Anti-aging Drugs Sales Breakdown by Application
11.3.1 India Anti-aging Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-aging Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anti-aging Drugs Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Anti-aging Drugs Products Offered
12.1.5 Allergan Recent Development
12.2 Galderma
12.2.1 Galderma Corporation Information
12.2.2 Galderma Business Overview
12.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Galderma Anti-aging Drugs Products Offered
12.2.5 Galderma Recent Development
12.3 LG Life Science
12.3.1 LG Life Science Corporation Information
12.3.2 LG Life Science Business Overview
12.3.3 LG Life Science Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LG Life Science Anti-aging Drugs Products Offered
12.3.5 LG Life Science Recent Development
12.4 Merz Pharma
12.4.1 Merz Pharma Corporation Information
12.4.2 Merz Pharma Business Overview
12.4.3 Merz Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merz Pharma Anti-aging Drugs Products Offered
12.4.5 Merz Pharma Recent Development
12.5 Medytox
12.5.1 Medytox Corporation Information
12.5.2 Medytox Business Overview
12.5.3 Medytox Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Medytox Anti-aging Drugs Products Offered
12.5.5 Medytox Recent Development
12.6 Hugel
12.6.1 Hugel Corporation Information
12.6.2 Hugel Business Overview
12.6.3 Hugel Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hugel Anti-aging Drugs Products Offered
12.6.5 Hugel Recent Development
12.7 IMEIK
12.7.1 IMEIK Corporation Information
12.7.2 IMEIK Business Overview
12.7.3 IMEIK Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IMEIK Anti-aging Drugs Products Offered
12.7.5 IMEIK Recent Development
12.8 Haohai Bio
12.8.1 Haohai Bio Corporation Information
12.8.2 Haohai Bio Business Overview
12.8.3 Haohai Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Haohai Bio Anti-aging Drugs Products Offered
12.8.5 Haohai Bio Recent Development
12.9 Daewoong Pharmaceutical
12.9.1 Daewoong Pharmaceutical Corporation Information
12.9.2 Daewoong Pharmaceutical Business Overview
12.9.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Daewoong Pharmaceutical Anti-aging Drugs Products Offered
12.9.5 Daewoong Pharmaceutical Recent Development
12.10 Bloomage
12.10.1 Bloomage Corporation Information
12.10.2 Bloomage Business Overview
12.10.3 Bloomage Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bloomage Anti-aging Drugs Products Offered
12.10.5 Bloomage Recent Development
12.11 Suneva Medical
12.11.1 Suneva Medical Corporation Information
12.11.2 Suneva Medical Business Overview
12.11.3 Suneva Medical Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Suneva Medical Anti-aging Drugs Products Offered
12.11.5 Suneva Medical Recent Development
12.12 SciVision Biotech
12.12.1 SciVision Biotech Corporation Information
12.12.2 SciVision Biotech Business Overview
12.12.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 SciVision Biotech Anti-aging Drugs Products Offered
12.12.5 SciVision Biotech Recent Development
13 Anti-aging Drugs Manufacturing Cost Analysis
13.1 Anti-aging Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-aging Drugs
13.4 Anti-aging Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-aging Drugs Distributors List
14.3 Anti-aging Drugs Customers
15 Market Dynamics
15.1 Anti-aging Drugs Market Trends
15.2 Anti-aging Drugs Drivers
15.3 Anti-aging Drugs Market Challenges
15.4 Anti-aging Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-aging Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anti-aging Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anti-aging Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anti-aging Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Anti-aging Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anti-aging Drugs Revenue Share by Region (2016-2021)
Table 8. Global Anti-aging Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Anti-aging Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anti-aging Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anti-aging Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anti-aging Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Anti-aging Drugs Sales Share by Company (2016-2021)
Table 14. Global Anti-aging Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anti-aging Drugs Revenue Share by Company (2016-2021)
Table 16. Global Anti-aging Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-aging Drugs as of 2020)
Table 17. Global Anti-aging Drugs Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Anti-aging Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-aging Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-aging Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Anti-aging Drugs Sales Share by Type (2016-2021)
Table 23. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anti-aging Drugs Price (US$/Unit) by Type (2016-2021)
Table 25. Global Anti-aging Drugs Sales Share by Type (2022-2027)
Table 26. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anti-aging Drugs Revenue Share by Type (2022-2027)
Table 28. Global Anti-aging Drugs Price (US$/Unit) by Type (2022-2027)
Table 29. Global Anti-aging Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Anti-aging Drugs Sales Share by Application (2016-2021)
Table 31. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anti-aging Drugs Price (US$/Unit) by Application (2016-2021)
Table 33. Global Anti-aging Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Anti-aging Drugs Sales Share by Application (2022-2027)
Table 35. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anti-aging Drugs Revenue Share by Application (2022-2027)
Table 37. Global Anti-aging Drugs Price (US$/Unit) by Application (2022-2027)
Table 38. North America Anti-aging Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Anti-aging Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Anti-aging Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anti-aging Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Anti-aging Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Anti-aging Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Anti-aging Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Anti-aging Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Anti-aging Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Anti-aging Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Anti-aging Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Anti-aging Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Anti-aging Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Anti-aging Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Anti-aging Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anti-aging Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Anti-aging Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Anti-aging Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-aging Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Anti-aging Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Anti-aging Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Anti-aging Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Anti-aging Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Anti-aging Drugs Sales Market Share by Application (2022-2027)
Table 62. China Anti-aging Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Anti-aging Drugs Sales Market Share by Company (2016-2021)
Table 64. China Anti-aging Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anti-aging Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Anti-aging Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Anti-aging Drugs Sales Market Share by Type (2016-2021)
Table 68. China Anti-aging Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Anti-aging Drugs Sales Market Share by Type (2022-2027)
Table 70. China Anti-aging Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Anti-aging Drugs Sales Market Share by Application (2016-2021)
Table 72. China Anti-aging Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Anti-aging Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Anti-aging Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Anti-aging Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Anti-aging Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anti-aging Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Anti-aging Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Anti-aging Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Anti-aging Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Anti-aging Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Anti-aging Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Anti-aging Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Anti-aging Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Anti-aging Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anti-aging Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Anti-aging Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anti-aging Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anti-aging Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anti-aging Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Anti-aging Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anti-aging Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Anti-aging Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anti-aging Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Anti-aging Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anti-aging Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Anti-aging Drugs Sales Market Share by Application (2022-2027)
Table 98. India Anti-aging Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Anti-aging Drugs Sales Market Share by Company (2016-2021)
Table 100. India Anti-aging Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anti-aging Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Anti-aging Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Anti-aging Drugs Sales Market Share by Type (2016-2021)
Table 104. India Anti-aging Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Anti-aging Drugs Sales Market Share by Type (2022-2027)
Table 106. India Anti-aging Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Anti-aging Drugs Sales Market Share by Application (2016-2021)
Table 108. India Anti-aging Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Anti-aging Drugs Sales Market Share by Application (2022-2027)
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Allergan Anti-aging Drugs Product
Table 114. Allergan Recent Development
Table 115. Galderma Corporation Information
Table 116. Galderma Description and Business Overview
Table 117. Galderma Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Galderma Anti-aging Drugs Product
Table 119. Galderma Recent Development
Table 120. LG Life Science Corporation Information
Table 121. LG Life Science Description and Business Overview
Table 122. LG Life Science Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. LG Life Science Anti-aging Drugs Product
Table 124. LG Life Science Recent Development
Table 125. Merz Pharma Corporation Information
Table 126. Merz Pharma Description and Business Overview
Table 127. Merz Pharma Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Merz Pharma Anti-aging Drugs Product
Table 129. Merz Pharma Recent Development
Table 130. Medytox Corporation Information
Table 131. Medytox Description and Business Overview
Table 132. Medytox Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Medytox Anti-aging Drugs Product
Table 134. Medytox Recent Development
Table 135. Hugel Corporation Information
Table 136. Hugel Description and Business Overview
Table 137. Hugel Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Hugel Anti-aging Drugs Product
Table 139. Hugel Recent Development
Table 140. IMEIK Corporation Information
Table 141. IMEIK Description and Business Overview
Table 142. IMEIK Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. IMEIK Anti-aging Drugs Product
Table 144. IMEIK Recent Development
Table 145. Haohai Bio Corporation Information
Table 146. Haohai Bio Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Haohai Bio Description and Business Overview
Table 148. Haohai Bio Anti-aging Drugs Product
Table 149. Haohai Bio Recent Development
Table 150. Daewoong Pharmaceutical Corporation Information
Table 151. Daewoong Pharmaceutical Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Daewoong Pharmaceutical Description and Business Overview
Table 153. Daewoong Pharmaceutical Anti-aging Drugs Product
Table 154. Daewoong Pharmaceutical Recent Development
Table 155. Bloomage Corporation Information
Table 156. Bloomage Description and Business Overview
Table 157. Bloomage Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Bloomage Anti-aging Drugs Product
Table 159. Bloomage Recent Development
Table 160. Suneva Medical Corporation Information
Table 161. Suneva Medical Description and Business Overview
Table 162. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Suneva Medical Anti-aging Drugs Product
Table 164. Suneva Medical Recent Development
Table 165. SciVision Biotech Corporation Information
Table 166. SciVision Biotech Description and Business Overview
Table 167. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. SciVision Biotech Anti-aging Drugs Product
Table 169. SciVision Biotech Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Anti-aging Drugs Distributors List
Table 173. Anti-aging Drugs Customers List
Table 174. Anti-aging Drugs Market Trends
Table 175. Anti-aging Drugs Market Drivers
Table 176. Anti-aging Drugs Market Challenges
Table 177. Anti-aging Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-aging Drugs Product Picture
Figure 2. Global Anti-aging Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-aging Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Beauty Parlor Examples
Figure 8. Others Examples
Figure 9. Global Anti-aging Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-aging Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Anti-aging Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Anti-aging Drugs Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 13. Global Anti-aging Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Anti-aging Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Anti-aging Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Anti-aging Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Anti-aging Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Anti-aging Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Anti-aging Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Anti-aging Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Anti-aging Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Anti-aging Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Anti-aging Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anti-aging Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Anti-aging Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Anti-aging Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Anti-aging Drugs Players Market Share by Revenue in Anti-aging Drugs: 2016 & 2020
Figure 28. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Anti-aging Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Anti-aging Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Anti-aging Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Anti-aging Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Anti-aging Drugs Sales Market Share by Type in 2020
Figure 34. North America Anti-aging Drugs Sales Market Share by Application in 2020
Figure 35. Europe Anti-aging Drugs Sales Market Share by Type in 2020
Figure 36. Europe Anti-aging Drugs Sales Market Share by Application in 2020
Figure 37. China Anti-aging Drugs Sales Market Share by Type in 2020
Figure 38. China Anti-aging Drugs Sales Market Share by Application in 2020
Figure 39. Japan Anti-aging Drugs Sales Market Share by Type in 2020
Figure 40. Japan Anti-aging Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Anti-aging Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Anti-aging Drugs Sales Market Share by Application in 2020
Figure 43. India Anti-aging Drugs Sales Market Share by Type in 2020
Figure 44. India Anti-aging Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Anti-aging Drugs
Figure 47. Manufacturing Process Analysis of Anti-aging Drugs
Figure 48. Anti-aging Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界のアンチエイジング薬＆デバイス市場規模・現状・予測（2021年-2027年） Aging is a natural phenomenon that is peculiar to all living things. However, accumulating findings indicate that senescence could be postponed or prevented by certain approaches. Substantial evidence has emerged supporting the possibility of radical human health and lifespan extension, in particula…- 世界のアンチエイジング成分市場規模・現状・予測（2021年-2027年） Anti-aging supplements are a set of products that often include powdered supplements, skin creams, vitamins, and facial masks. Collagen peptides can reduce signs of aging by stimulating new collagen growth, promoting collagen production, and relaxing wrinkles. They are also a natural source of prote…
- アンチエイジング成分のグローバル市場：規模・現状・予測2019-2025 Anti-aging supplements are a set of products that often include powdered supplements, skin creams, vitamins, and facial masks.Collagen peptides can reduce signs of aging by stimulating new collagen growth, promoting collagen production, and relaxing wrinkles. They are also a natural source of protei…
- アンチエイジング成分のグローバル市場：規模・現状・予測2019-2025 Anti-aging supplements are a set of products that often include powdered supplements, skin creams, vitamins, and facial masks.Collagen peptides can reduce signs of aging by stimulating new collagen growth, promoting collagen production, and relaxing wrinkles. They are also a natural source of protei…
- アンチエイジング化粧品のグローバル市場調査 2019年 The global Anti-Aging Cosmetics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anti-Aging Cosmetics volume and value at global level, regional level and company level. From a global perspective, th…